Who founded Q Bio, Inc.?

Q Bio, Inc. was founded by Jeffrey Kaditz.

Who are Q Bio, Inc.'s investors?

Q Bio, Inc.'s investors include Alumni Ventures, Andreessen Horowitz, Beast Ventures, Evolution Ventures, Mana Ventures, What If Ventures.

How much funding has Q Bio, Inc. raised?

Q Bio, Inc. has disclosed $27.1M raised across 1 round.

Where is Q Bio, Inc. headquartered?

Q Bio, Inc. is headquartered in San Carlos, US.

Q Bio, Inc.

San Carlos, US · Delaware corporation · 6 known investors

Find your way into Q Bio, Inc.

Your email: who you already know at Q Bio, Inc., and who your contacts know
2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Q Bio, Inc. team
Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

Q.bio provides quantitative biology assessments and longitudinal health monitoring for preventive care, offering comprehensive measurable exams at the scale of premium care providers.

AI & Machine Learning Biotech Digital Health Healthtech

Founders & leadership

Jeffrey KaditzFounder

Clarissa ShenExecutive

Board

Terry DoyleBoard director

Vijay Pande, Ph.D.Board director

Investors · 6

Alumni Ventureslisted by Alumni VenturesManchester · $100K – $10M

How we know: av.vc · Not right? Tell us

Andreessen Horowitzlisted by Andreessen HorowitzMenlo Park · $500K – $50M

How we know: a16z's portfolio · a partner's Signal profile · Not right? Tell us

Beast Ventureslisted by Beast VenturesHong Kong

How we know: open dataset · 5k.vc investor directory · Not right? Tell us

Evolution Ventureslisted by Evolution VenturesCupertino

Mana VenturesreportedEstero

How we know: the VCSheet dataset · Not right? Tell us

What If VenturesreportedFrisco

How we know: a partner's Signal profile · Not right? Tell us

Reported raises · per SEC filings

Form D private placements

$27.1M disclosed across 1 round · 2024

▶$27.1MraisedJul 2024 · 14 investors · Other Technology

Rule 506(b)

Officers, directors & promoters on the filing

Terry DoyleDirector
Vijay Pande, Ph.D.Director
Clarissa ShenExecutive Officer
Jeffrey KaditzExecutive Officer, Director, Promoter

Offering amount: $27.1M
Amount sold: $27.1M
First sale: Mar 2024
Incorporated: Corporation, Delaware
Federal exemptions: 06b

Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Related companies · 2

Q32 BioQ32 Bio is a biotechnology company developing therapies for autoimmune and inflammatory diseases, with a scientific focus on the complement system and immune regulation in conditions such as inflammation, autoimmunity and fibrosis. The company was formed through a merger with Homology Medicines in 2024 and is led by a team with immunology and biopharmaceutical drug development experience.

Qu BiologicsQu Biologics develops treatments aimed at cancer, chronic inflammatory diseases, and metabolic diseases by restoring normal immune function. It operates in the biotech and immunotherapy space.

Companies working in the same space as Q Bio, Inc..

Frequently asked questions

What does Q Bio, Inc. do?: Q.bio provides quantitative biology assessments and longitudinal health monitoring for preventive care, offering comprehensive measurable exams at the scale of premium care providers.
Who founded Q Bio, Inc.?: Q Bio, Inc. was founded by Jeffrey Kaditz.
Who are Q Bio, Inc.'s investors?: Q Bio, Inc.'s investors include Alumni Ventures, Andreessen Horowitz, Beast Ventures, Evolution Ventures, Mana Ventures, What If Ventures.
How much funding has Q Bio, Inc. raised?: Q Bio, Inc. has disclosed $27.1M raised across 1 round.
Where is Q Bio, Inc. headquartered?: Q Bio, Inc. is headquartered in San Carlos, US.